Survivor(n = 176) | Non-survivor(n = 50) | P-value | |
---|---|---|---|
Males (%) | 82 (46.60%) | 31 (62%) | 0.077 |
Age (years) | 49.93 (15.35) | 67.82 (15.73) | < 0.001 |
Onset time (day) | 7.16 (3.86) | 6.54 (3.71) | 0.619 |
Hypertension (%) | 47 (26.70%) | 37 (74%) | < 0.001 |
T2DM (%) | 28 (15.91%) | 17 (34%) | 0.008 |
CHD (%) | 6 (3.41%) | 7 (14%) | 0.010 |
COPD (%) | 3 (1.70%) | 3 (6.00%) | 0.124 |
WBC (109) | 5.15 (3.71–6.44) | 5.73 (4.18–7.95) | 0.078 |
N (109) | 3.34 (2.34–4.76) | 4.32 (2.97–7.05) | 0.002 |
L (109) | 1.10 (0.75–1.52) | 0.66 (0.46–0.92) | < 0.001 |
N/L | 2.98 (1.70–5.51) | 6.18 (3.58–12.78) | < 0.001 |
ALT (U/L) | 19.70 (13.60–33.65) | 21.05 (14.33–29.48) | 0.819 |
AST (U/L) | 21.35 (17.20–32.95) | 31.50 (22.40–44.33) | 0.001 |
ALB (g/L) | 39.24 (5.25) | 35.55 (4.30) | < 0.001 |
sCr (μmol/L) | 64.90 (52.20–75.93) | 76.00 (58.00–109.20) | 0.003 |
BUN (mmol/L) | 3.97 (3.13–5.25) | 6.60 (4.60–10.58) | < 0.001 |
CRP (mg/dL) | 1.52 (0.28–5.03) | 6.10 (3.53–8.84) | < 0.001 |
D-dimer (μg/mL) | 0.56 (0.28–1.28) | 6.21 (1.27–19.73) | < 0.001 |